Ahles TA - Search Results

1

Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.

Saykin AJ, Ahles TA, McDonald BC. Saykin AJ, et al. Among authors: ahles ta. Semin Clin Neuropsychiatry. 2003 Oct;8(4):201-16. Semin Clin Neuropsychiatry. 2003. PMID: 14613048 Review.

2

Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?

Mandelblatt JS, Hurria A, McDonald BC, Saykin AJ, Stern RA, VanMeter JW, McGuckin M, Traina T, Denduluri N, Turner S, Howard D, Jacobsen PB, Ahles T; Thinking and Living With Cancer Study. Mandelblatt JS, et al. Semin Oncol. 2013 Dec;40(6):709-25. doi: 10.1053/j.seminoncol.2013.09.006. Semin Oncol. 2013. PMID: 24331192 Free PMC article. Review.

3

Breast cancer chemotherapy-related cognitive dysfunction.

Ahles TA, Saykin AJ. Ahles TA, et al. Clin Breast Cancer. 2002 Dec;3 Suppl 3:S84-90. doi: 10.3816/cbc.2002.s.018. Clin Breast Cancer. 2002. PMID: 12533268 Review.

4

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.

Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA. Ahles TA, et al. Psychooncology. 2003 Sep;12(6):612-9. doi: 10.1002/pon.742. Psychooncology. 2003. PMID: 12923801

5

Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments.

McAllister TW, Ahles TA, Saykin AJ, Ferguson RJ, McDonald BC, Lewis LD, Flashman LA, Rhodes CH. McAllister TW, et al. Among authors: ahles ta. Curr Psychiatry Rep. 2004 Oct;6(5):364-71. doi: 10.1007/s11920-004-0023-y. Curr Psychiatry Rep. 2004. PMID: 15355759 Review.

6

Candidate mechanisms for chemotherapy-induced cognitive changes.

Ahles TA, Saykin AJ. Ahles TA, et al. Nat Rev Cancer. 2007 Mar;7(3):192-201. doi: 10.1038/nrc2073. Nat Rev Cancer. 2007. PMID: 17318212 Free PMC article. Review.

7

Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates.

Conroy SK, McDonald BC, Ahles TA, West JD, Saykin AJ. Conroy SK, et al. Among authors: ahles ta. Brain Imaging Behav. 2013 Dec;7(4):491-500. doi: 10.1007/s11682-013-9240-5. Brain Imaging Behav. 2013. PMID: 23793983 Free PMC article. Clinical Trial.

8

Cognitive effects of standard-dose chemotherapy in patients with cancer.

Ahles TA, Saykin A. Ahles TA, et al. Cancer Invest. 2001;19(8):812-20. doi: 10.1081/cnv-100107743. Cancer Invest. 2001. PMID: 11768035 Review.

9

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking.

Ahles TA, Li Y, McDonald BC, Schwartz GN, Kaufman PA, Tsongalis GJ, Moore JH, Saykin AJ. Ahles TA, et al. Psychooncology. 2014 Dec;23(12):1382-90. doi: 10.1002/pon.3545. Epub 2014 Apr 30. Psychooncology. 2014. PMID: 24789331 Free PMC article.

10

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM. Ahles TA, et al. J Clin Oncol. 2002 Jan 15;20(2):485-93. doi: 10.1200/JCO.2002.20.2.485. J Clin Oncol. 2002. PMID: 11786578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters